These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 27696732
41. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol. Paulshus Sundlisæter N, Olsen IC, Aga AB, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA, ARCTIC study group. Rheumatology (Oxford); 2018 Nov 01; 57(11):2022-2031. PubMed ID: 30053199 [Abstract] [Full Text] [Related]
42. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase. Knevel R, Lukas C, van der Heijde D, Rincheval N, Combe B, van der Helm-van Mil AH. Ann Rheum Dis; 2013 Apr 01; 72(4):590-5. PubMed ID: 23393145 [Abstract] [Full Text] [Related]
43. Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy. Ranganath VK, Motamedi K, Haavardsholm EA, Maranian P, Elashoff D, McQueen F, Duffy EL, Bathon JM, Curtis JR, Chen W, Moreland L, Louie J, Amjadi S, O'Dell J, Cofield SS, St Clair EW, Bridges SL, Paulus HE. Arthritis Care Res (Hoboken); 2015 Jul 01; 67(7):929-39. PubMed ID: 25581612 [Abstract] [Full Text] [Related]
44. Treat-to-target approach in daily clinical practice in Pakistani patients with early Rheumatoid Arthritis. Farman S, Ahmad NM, Saeed MA, Asad K, Shabbir G. J Coll Physicians Surg Pak; 2015 Feb 01; 25(2):129-33. PubMed ID: 25703758 [Abstract] [Full Text] [Related]
46. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity. Krieckaert CL, Jamnitski A, Nurmohamed MT, Kostense PJ, Boers M, Wolbink G. Arthritis Rheum; 2012 Dec 01; 64(12):3850-5. PubMed ID: 22933315 [Abstract] [Full Text] [Related]
47. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target. Legrand J, Kirchgesner T, Sokolova T, Vande Berg B, Durez P. Joint Bone Spine; 2019 Oct 01; 86(5):594-599. PubMed ID: 30928534 [Abstract] [Full Text] [Related]
50. Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort. Vesperini V, Lukas C, Fautrel B, Le Loet X, Rincheval N, Combe B. Arthritis Care Res (Hoboken); 2013 Dec 01; 65(12):1899-906. PubMed ID: 23836776 [Abstract] [Full Text] [Related]
53. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission. Lisbona MP, Pàmies A, Ares J, Almirall M, Navallas M, Solano A, Maymó J. J Rheumatol; 2014 Aug 01; 41(8):1623-9. PubMed ID: 24986851 [Abstract] [Full Text] [Related]
54. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Hetland ML, Stengaard-Pedersen K, Junker P, Østergaard M, Ejbjerg BJ, Jacobsen S, Lottenburger T, Hansen I, Tarp U, Andersen LS, Svendsen A, Pedersen JK, Lauridsen UB, Ellingsen T, Lindegaard H, Pødenphant J, Vestergaard A, Jurik AG, Hørslev-Petersen K, CIMESTRA study group. Ann Rheum Dis; 2010 Oct 01; 69(10):1789-95. PubMed ID: 20444751 [Abstract] [Full Text] [Related]
55. Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis. Besselink NJ, Westgeest AAA, Klaasen R, Gamala M, van Woerkom JM, Tekstra J, Verhoeven MMA, Van Spil WE, Lafeber FPJG, Marijnissen ACA, Van Laar JM, Jacobs JWG. Trials; 2019 Apr 17; 20(1):226. PubMed ID: 30999969 [Abstract] [Full Text] [Related]
56. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T. J Rheumatol; 2013 Apr 17; 40(4):386-93. PubMed ID: 23378463 [Abstract] [Full Text] [Related]
57. Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New Zealand. Raja R, Chapman PT, O'Donnell JL, Ipenburg J, Frampton C, Hurst M, Stamp LK. J Rheumatol; 2012 Nov 17; 39(11):2098-103. PubMed ID: 22984270 [Abstract] [Full Text] [Related]
58. Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study. Uhlig T, Lie E, Norvang V, Lexberg ÅS, Rødevand E, Krøll F, Kalstad S, Olsen IC, Kvien TK. J Rheumatol; 2016 Apr 17; 43(4):716-23. PubMed ID: 26879358 [Abstract] [Full Text] [Related]
59. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Combe B, Logeart I, Belkacemi MC, Dadoun S, Schaeverbeke T, Daurès JP, Dougados M. Ann Rheum Dis; 2015 Apr 17; 74(4):724-9. PubMed ID: 24399234 [Abstract] [Full Text] [Related]